Progyny Inc
Research Progyny Inc (PGNY) on Bullrun: valuation model: 27.3% overvalued, market cap USD 2.26B, P/E 37.5. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerPGNY
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryHealthcare Plans
- CurrencyUSD
- Valuation signal27.3% overvalued
- Market capUSD 2.26B
- P/E37.5
- Financial periodFY2025
- RevenueUSD 1.29B
- Revenue growth10.4%
- Net incomeUSD 58.52M
- Free cash flowUSD 191.78M
- Gross margin23.6%
Valuation Snapshot
Bullrun's latest valuation model marks Progyny Inc as 27.3% overvalued; latest market cap is USD 2.26B; P/E is 37.5.
About Progyny Inc
Progyny, Inc., a benefits management company, provides fertility, family building, and women's health benefits solutions in the United States. It offers fertility benefits solutions, such as differentiated benefits plan design that includes smart cycle treatment bundle; personalized concierge-style member support services; and a selective network of fertility specialists.
Frequently asked questions
Is Progyny Inc overvalued or undervalued?
Bullrun's valuation model currently marks Progyny Inc as 27.3% overvalued.
What is Progyny Inc's market cap?
Progyny Inc's market capitalization is USD 2.26B.
What is Progyny Inc's P/E ratio?
Progyny Inc's price-to-earnings (P/E) ratio is 37.5.
What does Progyny Inc do?
Progyny, Inc., a benefits management company, provides fertility, family building, and women's health benefits solutions in the United States. It offers fertility benefits solutions, such as differentiated benefits plan design that includes smart cycle treatment bundle;